Back to Search
Start Over
Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial
- Source :
- Journal of Hepatology. 77:S1
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Hepatology
Subjects
Details
- ISSN :
- 01688278
- Volume :
- 77
- Database :
- OpenAIRE
- Journal :
- Journal of Hepatology
- Accession number :
- edsair.doi...........7d64f3b540bd404b6f45782583ac5d3b